RVXCF

Resverlogix Corp. RVXCF

RVXCF
Resverlogix Corp. BIOAF
Bioasis Technologies Inc. ZHCLF
Zenith Capital Corp. PMN
ProMIS Neurosciences, Inc. FENC
Fennec Pharmaceuticals Inc. RVX.TO
Resverlogix Corp. SRBCF
Sirona Biochem Corp. SEOVF
Sernova Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RVXCF BIOAF ZHCLF PMN FENC RVX.TO SRBCF SEOVF
6M 120.00 % -50.00 % 99 900.00 % -20.09 % 57.02 % 162.50 % -44.62 % -1.11 %
YTD 92.98 % 100.00 % 100.00 % -52.19 % 31.56 % 110.00 % -77.36 % -19.55 %
1Y 59.81 % 100.00 % 100.00 % -54.10 % 82.27 % 75.00 % -82.66 % -35.20 %
3Y -48.15 % -99.81 % -33.33 % -92.29 % 5.15 % -41.67 % -88.70 % -78.80 %
5Y -92.14 % -99.93 % 870.87 % -92.35 % 12.74 % -90.63 % -95.59 % -40.17 %
10Y -94.84 % -99.98 % 9 900.00 % -89.07 % -31.04 % -93.75 % -93.00 % -47.17 %
From the beginning -97.43 % -99.97 % 9 900.00 % -99.36 % -31.04 % -95.51 % -82.83 % -89.66 %

Dividend